Stockscreener 앱 받기
3.80
7.09%
-0.29
시간 외 거래:
3.84
0.04
+1.05%
전일 마감가:
$4.09
열려 있는:
$4.11
하루 거래량:
107.43K
Relative Volume:
1.49
시가총액:
$37.74M
수익:
$20.34M
순이익/손실:
$-24.52M
주가수익비율:
-1.0626
EPS:
-3.5761
순현금흐름:
$-5.92M
1주 성능:
-8.43%
1개월 성능:
-35.81%
6개월 성능:
-24.59%
1년 성능:
-36.67%
1일 변동 폭
$3.80
$4.15
1주일 범위
$3.80
$4.42
52주 변동 폭
$3.80
$10.48
Scynexis Inc Stock (SCYX) Company Profile
명칭
Scynexis Inc
전화
201-884-5485
주소
1 EVERTRUST PLAZA, JERSEY CITY, NJ
Compare SCYX vs TAK, HLN, TEVA, ZTS, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SCYX
Scynexis Inc
|
3.80 | 40.62M | 20.34M | -24.52M | -5.92M | -3.5761 |
TAK
Takeda Pharmaceutical Co Adr
|
15.42 | 49.83B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
8.87 | 40.04B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.56 | 39.23B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
77.26 | 33.52B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
551.47 | 23.33B | 3.17B | 1.29B | 1.01B | 27.09 |
Scynexis Inc Stock (SCYX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-01-22 | 개시 | Guggenheim | Buy |
| 2021-01-06 | 개시 | Cantor Fitzgerald | Overweight |
| 2018-07-11 | 업그레이드 | Needham | Hold → Buy |
| 2018-06-27 | 개시 | Maxim Group | Buy |
| 2017-10-24 | 개시 | Guggenheim | Buy |
| 2017-07-10 | 개시 | ROTH Capital | Buy |
| 2017-05-09 | 다운그레이드 | Needham | Buy → Hold |
| 2017-03-03 | 재확인 | RBC Capital Mkts | Outperform |
| 2016-10-20 | 개시 | H.C. Wainwright | Buy |
| 2016-10-07 | 업그레이드 | WBB Securities | Buy → Strong Buy |
| 2016-10-03 | 재개 | Brean Capital | Buy |
| 2016-08-17 | 개시 | Guggenheim | Buy |
| 2016-08-09 | 재확인 | Needham | Buy |
| 2016-08-09 | 업그레이드 | WBB Securities | Speculative Buy → Buy |
| 2016-03-28 | 개시 | Brean Capital | Buy |
| 2015-12-29 | 개시 | WBB Securities | Speculative Buy |
| 2015-11-16 | 재확인 | RBC Capital Mkts | Outperform |
| 2015-06-10 | 개시 | Needham | Buy |
| 2014-05-29 | 개시 | Canaccord Genuity | Buy |
| 2014-05-29 | 개시 | RBC Capital Mkts | Outperform |
모두보기
Scynexis Inc 주식(SCYX)의 최신 뉴스
SCYNEXIS (SCYX) Holds Near Support Amid Quiet TradingFast Moving Stocks - newsline.com
SCYNEXIS Q1 2026 Earnings: EPS Misses Estimates as Company Reports No RevenueInvestor Earnings Call - newsline.com
SCYNEXIS, Inc. Hits New 52-Week High of $5.62, Up 157.49% - MarketsMojo
SCYNEXIS (SCYX) Picks Up Slightly as Stock Bounces Within Established RangeDiagonal Spread Trade - newsline.com
SCYNEXIS (SCYX) Slides 2.6% as Stock Approaches Key SupportATR Trailing Stop - newsline.com
Total liabilities of SCYNEXIS, Inc. – MUN:135 - TradingView
SCYNEXIS, Inc. Balance Sheet – MUN:135 - TradingView
Net debt of SCYNEXIS, Inc. – FWB:135 - TradingView
Pretax income of SCYNEXIS, Inc. – TRADEGATE:135 - TradingView
Free cash flow of SCYNEXIS, Inc. – FWB:135 - TradingView
SCYNEXIS, Inc. Cash Flow – MUN:135 - TradingView
SCYNEXIS, Inc. Cash Flow – FWB:135 - TradingView
Pretax income of SCYNEXIS, Inc. – GETTEX:135 - TradingView
Working capital per share of SCYNEXIS, Inc. – TRADEGATE:135 - TradingView
SCYNEXIS, Inc. Statistics – TRADEGATE:135 - TradingView
Net margin % of SCYNEXIS, Inc. – MUN:135 - TradingView
Net income of SCYNEXIS, Inc. – TRADEGATE:135 - TradingView
SCYNEXIS Inc (FRA:135) Stock Earnings Transcripts - GuruFocus
SCYNEXIS Inc (FRA:135) Stock Price & 30 Year Financial Data - GuruFocus
SCYNEXIS Inc (STU:135) Stock Price & 30 Year Financial Data - GuruFocus
Scynexis Shareholder Alert - TMX Newsfile
SCYNEXIS Inc. (SCYX) Declines 4.12%: Stock Approaches Key Support at $0.66Put Call Ratio - newsline.com
SCYNEXIS to implement 1-for-8 reverse stock split - MSN
Scynexis (SCYX) completes 1-for-8 reverse split and cuts authorized shares - Stock Titan
SCYX Q1 2026 Earnings: EPS Misses Estimates as No Revenue Reported, Stock Rises 4.91%Share Repurchase Impact - The Legal Advocate
SCYNEXIS (SCYX) Slips Over 4%: Support Level in Focus Amid Biotech Sector HeadwindsVolume Dry Up - newsline.com
SCYNEXIS (SCYX) Falls 6.88%: Key Support and Resistance Levels Under ScrutinyNews Sentiment - The Legal Advocate
Stock Market Today: S&P 500, Dow, Nasdaq Futures Up Amid US 'Defensive Strikes' On Iran— Elbit Systems, Intuitive Machines, Zscaler In Focus (UPDATED) - Benzinga
SCYX Q1 2026 Earnings: EPS Misses Estimates; Stock Rises Despite Wider-Than-Expected LossFinancial Data - The Legal Advocate
SCYNEXIS Announces One-for-Eight Reverse Stock Split - The Manila Times
SCYNEXIS (SCYX) Announces 1-for-8 Reverse Stock Split to Meet Na - GuruFocus
SCYNEXIS announces 1-for-8 reverse stock split effective May 29 - Investing.com UK
SCYNEXIS Stockholders Approve One-for-Eight Reverse Split - TipRanks
SCYNEXIS announces 1-for-8 reverse stock split effective May 29 By Investing.com - Investing.com South Africa
Scynexis stock falls 7% on reverse stock split announcement By Investing.com - Investing.com South Africa
Scynexis stock falls 7% on reverse stock split announcement - Investing.com
SCYNEXIS (SCYX) approves 1-for-8 reverse stock split and major cut to authorized shares - Stock Titan
SCYNEXIS Inc Extraordinary Shareholders Meeting Transcript - GuruFocus
SCYX: Shareholders approved a reverse stock split and reduction of authorized shares - TradingView
SCYX: Reverse stock split and share reduction approved; no questions or other proposals raised - TradingView
SCYNEXIS (SCYX) Falls -7.43% — Watching $0.66 Support 2026-05-18Overbought Alert - Newser
Why did SCYX stock jump 10% in pre-market today? - MSN
Press Releases about SCYNEXIS, Inc.Common Stock - The Chronicle-Journal
CVI Investments and Heights disclose 6.2% stake in SCYNEXIS (SCYX) - Stock Titan
SCYNEXIS (SCYX) price target increased by 20.73% to 4.28 - MSN
Maxim Group Maintains Scynexis(SCYX.US) With Buy Rating, Maintains Target Price $4 - Moomoo
Financial Overview of SCYX: Cash Position Strengthened - GuruFocus
Scynexis: Q1 Earnings Snapshot - marketscreener.com
Rare-disease biotech SCYNEXIS buys kidney-drug candidate, funds runway to 2029 - Stock Titan
BRIEF-Scynexis Q1 Operating Expenses USD 16.939 Million - TradingView
Scynexis Inc (SCYX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.95%
1.13%
자본화:
|
볼륨(24시간):